Search

everythinglearnresearchcommunity

for

Search:↓

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 can cause various skin issues, including rashes and lesions.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

The document concludes that alopecia is an incurable autoimmune disease with various treatments and that diet, as well as COVID-19, may impact it.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

Post-COVID-19 patients are at risk for hair loss.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Thyroid function may influence hair loss after COVID-19.